Relevant bibliographies by topics / Anticancer drug treatment / Books
To see the other types of publications on this topic, follow the link: Anticancer drug treatment.

Books on the topic 'Anticancer drug treatment'

Author: Grafiati
Published: 14 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 38 books for your research on the topic 'Anticancer drug treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Link, Wolfgang. Principles of Cancer Treatment and Anticancer Drug Development. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18722-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Manuel, Hidalgo. Principles of anticancer drug development. New York: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parfenov, E. A. Biometals and ligands for anticancer drug design. Commack, N.Y: Nova Science Publishers, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1946-, Lippert Bernhard, ed. Cisplatin: Chemistry and biochemistry of a leading anticancer drug. Zürich: Verlag Helvetica Chimica Acta, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Avendaño, Carmen. Medicinal chemistry of anticancer drugs. Amsterdam: Elsevier, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

J, Houghton Peter, and Houghton Janet A, eds. Preclinical and clinical modulation of anticancer drugs. Boca Raton: CRC Press, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1945-, Ojima Iwao, Vite Gregory D, Altmann Karl-Heinz, American Chemical Society. Division of Organic Chemistry, American Chemical Society. Division of Medicinal Chemistry, and American Chemical Society Meeting, eds. Anticancer agents: Frontiers in cancer chemotherapy. Washington, DC: American Chemical Society, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cho, William C. S. Evidence-based Anticancer Materia Medica. Dordrecht: Springer Science+Business Media B.V., 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lipp, H. P. Prevention and management of anticancer drug toxicity: The significance of clinical pharmacokinetics. Jena: Univ.-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Snapka, Robert M. The SV40 replicon model for analysis of anticancer drugs. Austin, TX: R.G. Landes, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

The SV40 replicon model for analysis of anticancer drugs. [San Diego, Calif.]: Academic Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

J, Zeller W., D'Incalci M, Newell D. R, and Novel approaches in cancer therapy (Heidelburg : 1993), eds. Novel approaches in anticancer drug design: Molecular modelling - new treatment strategies, novel approaches in cancer therapy. Basel: Karger, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

International Symposium on Novel Approaches in Cancer Therapy (1993 Heidelberg, Germany). Novel approaches in anticancer drug design: Molecular modelling, new treatment strategies : International Symposium on Novel Approaches in Cancer Therapy, Heidelberg, December 1-4, 1993. Edited by Zeller W. J, D'Incalci Maurizio, and Newell David R. Basel: Karger, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Frederick, Valeriote, and Baker Laurence H, eds. Biochemical modulation of anticancer agents: Experimental and clinical approaches : proceedings of the 18th Annual Detroit Cancer Symposium, Detroit, Michigan, USA, June 13-14, 1986. Boston: Nijhoff, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Convention, United States Pharmacopeial. Fact sheets on anticancer drugs. [Washington, D.C.?]: National Cancer Institute [distributor], 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Anticancer herbal drugs of India with special reference to ayurveda. Delhi: Sri Satguru Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Stephen, Neidle, and Waring Michael J, eds. Molecular aspects of anticancer drug-DNA interactions. Basingstoke: Macmillan, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Neidle, Stephen, and Michael J. Waring. Molecular Aspects of Anticancer Drug-DNA Interactions. Taylor & Francis Group, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Link, Wolfgang. Principles of Cancer Treatment and Anticancer Drug Development. Springer International Publishing AG, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Link, Wolfgang. Principles of Cancer Treatment and Anticancer Drug Development. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Lipp. Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics. Informa Healthcare, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

(Editor), Lori J. Goldstein, and Robert F. Ozols (Editor), eds. Anticancer Drug Resistance: Advances in Molecular and Clinical Research (Cancer Treatment and Research). Springer, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Medicinal Chemistry of Anticancer Drugs. Elsevier Science & Technology Books, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Avendano, Carmen, and J. Carlos Menendez. Medicinal Chemistry of Anticancer Drugs. Elsevier Science & Technology Books, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Avendano, Carmen, and J. Carlos Menendez. Medicinal Chemistry of Anticancer Drugs. Elsevier Science & Technology Books, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Medicinal Chemistry of Anticancer Drugs. Elsevier Science, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Avendano, Carmen, and J. Carlos Menendez. Medicinal Chemistry of Anticancer Drugs. Elsevier Science & Technology, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Singh, Rajesh Kumar, ed. Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150400741220101.

Full text
Abstract:
This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in pharmaceutical chemistry and are written to give a general overview of the topic to readers involved in all levels of research and decision-making in pharmaceutical chemistry and anti-cancer drug design. Part 1 of the book set covers these topics: - Heterocyclic anticancer compounds derived from natural sources with their mechanism of action - The role of terpenoids as anticancer compounds: an insight into prevention and treatment - Recent advances in synthesis and anticancer activity of benzothiazole hybrids as anticancer agents - Structure-activity relationship studies of novel hybrid quinoline and quinolone derivatives as anticancer agents - Tetrazoles: structure and activity relationship as anticancer agents - Progress in nitrogen and oxygen-based heterocyclic compounds for their anticancer activity: an update (2017-2020)
APA, Harvard, Vancouver, ISO, and other styles
29

(Editor), Iwao Ojima, Gregory D. Vite (Editor), and Karl-Heinz Altmann (Editor), eds. Anticancer Agents: Frontiers in Cancer Chemotherapy (Acs Symposium Series). An American Chemical Society Publication, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Zaikov, Gennadii Efremovich, and E. A. Parfenov. Biometals and Ligands for Anticancer Drug Design: Superoxide Dimutase Models in Combined Tumor Therapy. 2nd ed. Nova Science Pub Inc, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Parfenov, E. A. Biometals And Ligands For Anticancer Drug Design: Molecular Mechanisms of Superoxide Dimutase Models Antitumor Effects. NOVA SCIENCE PUBLISHERS, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches (Developments in Oncology). Springer, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Zeller, W. J., and M. D'Incalci. Novel Approaches in Anticancer Drug Design: Molecular Modelling - New Treatment Strategies : International Symposium on Novel Approaches in Cancer T (Contributions ... Oncology = Beitrage Zur Onkologie, Vol 49). S. Karger AG (Switzerland), 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Snapka, Robert M. SV40 Replicon Model for Analysis of Anticancer Drugs. Elsevier Science & Technology Books, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Avendano, Carmen, and J. Carlos Menendez. Medicinal Chemistry of Anticancer Drugs, Second Edition. Elsevier Science, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Atta-ur-Rahman and Khurshid Zaman, eds. Topics in Anti-Cancer Research: Volume 8. BENTHAM SCIENCE PUBLISHERS, 2019. http://dx.doi.org/10.2174/97898114043821190801.

Full text
Abstract:
Topics in Anti-Cancer Research covers new developments in the field of cancer. Novel drugs as anticancer agents include natural and synthetic phenazines and other anti-cancer compounds. It also encompasses the role of estrogen as endocrine disruptors and strategies targeting cancer stem cells for the treatment of different types of cancers, including myeloma and renal cell cancer. The diversity of researches and topics published in this eBook Series will be valuable to cancer researchers, clinicians, and cancer professionals aiming to develop novel anti-cancer targets for the treatment of various cancers. The topics covered in the eighth volume of this series are as follows: Novel Drugs for Multiple Myeloma Synthetic Estrogens are Endocrine Disruptors via Inhibition of AF1 Domain of ERs Recent Progress of Phenazines as Anticancer Agents Cancer Stem Cell Targeting for Anticancer Therapy: Strategies and Challenges
APA, Harvard, Vancouver, ISO, and other styles
37

Freifeld, Alison G. An Introduction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199938568.003.0100.

Full text
Abstract:
This chapter focuses on solid tumors and how they can be treated. Solid tumors, lymphomas, and leukemias represent a widely diverse array of cancers. Until recently, the general approach to treating all of them was to administer cytotoxic anticancer drugs that damage proliferating cells by interfering with mitosis and other essential steps in cellular replication. Localized solid tumors are largely treated by surgical resection and radiotherapy, with cytotoxic chemotherapy being commonly used adjunctively or in cases of metastatic disease. A major drawback of this approach has been the lack of specificity in that cytotoxic drugs will destroy actively dividing normal cells as well as malignant cells. The “shotgun approach” of using intensive cytotoxic chemotherapies has been the mainstay of cancer treatment for at least 6 decades. The chapter concludes that in addition to the tissue damage and immunomodulating effects of anticancer drugs, it should be remembered that cancers themselves may increase the chances for infection.
APA, Harvard, Vancouver, ISO, and other styles
38

Innominato, Pasquale F., and David Spiegel. Circadian rhythms, sleep, and anti-cancer treatments. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198778240.003.0016.

Full text
Abstract:
The circadian timing system temporally regulates biological functions relevant for psycho-physical wellbeing, spanning all the systems related to health. Hence, disruption of circadian rhythms, along with sleep cycles, is associated with the development of several diseases, including cancer. Moreover, altered circadian and sleep functions negatively impact on cancer patients’ quality of life and survival, above and beyond known determinants of outcome. This alteration can occur as a consequence of cancer, but also of anti-cancer treatments. Indeed, circadian rhythms govern also the ability of detoxifying chemotherapy agents across the 24 hours. Hence, adapting chemotherapy delivery to the molecular oscillations in relevant drug pathways can decrease toxicity to healthy cells, while increasing the number of cancer cells killing. This chronomodulated chemotherapy approach, together with the maintenance of proper circadian function throughtout the whole disease challenge, would finally result in safer and more active anticancer treatments, and in patients experiencing better quality and quantity of life.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Anticancer drug treatment' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography